Former Pfizer exec heads to Berlin Pharmaceutical Industry

> Berlin Pharmaceutical Industry, Thailand's leading manufacturer and marketer of generic pharmaceuticals, has named Amal Naj, a former senior VP at Pfizer, CEO and a member of the board.
> Vitae Pharmaceuticals today announced the appointment of Christine Brennan as chief business officer.
> Timothy Hayes, currently senior VP and region head for Bayer HealthCare's consumer care division in North America, will also lead the business unit's global business development function.
> Amneal Pharmaceuticals has tapped Shankar Hariharan as chief scientific officer/executive VP of specialty pharmaceuticals.
> Talecris Biotherapeutics has named Lafmin Morgan to its global commercial operations team as VP, U.S. product management.
> Australia's Starpharma Holdings has appointed Malcolm McColl to join the company's existing business development team as a VP.
> Advaxis has hired Reshma Singh as a senior scientist.
> Columbia Laboratories has appointed G. Frederick Wilkinson, executive VP, global brands, of Watson Pharmaceuticals as a director of the company. His appointment brings to eight the number of members of Columbia's board.
> Vyteris has named four new members to its scientific advisory board--David Cohen, Robert Shorr, David Filer and Michael Reidy.
> K-V Pharmaceutical has announced the election of David Sidransky as a new independent member of the board of directors.

Add new comment

Images
More information
  • Files must be less than 2 MB.
  • Allowed file types: png gif jpg jpeg.
Documents
More information
  • Files must be less than 2 MB.
  • Allowed file types: zip rar.